NCT02480257

Brief Summary

The investigators aim to refine and pilot test an innovative group treatment model for adolescent depression and anxiety, Training for Awareness, Resilience and Action (TARA) in a sample of 14-18 year olds with depressive or anxious symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 10, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 24, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

March 22, 2022

Status Verified

March 1, 2022

Enrollment Period

1.9 years

First QC Date

June 10, 2015

Last Update Submit

March 7, 2022

Conditions

Keywords

interventionemotion regulationfMRImindfulnessyoga-based movement

Outcome Measures

Primary Outcomes (2)

  • Reynolds Adolescent Depression Scale (RADS-2)

    Self report, 30-item measure of 4 dimensions of depression: Dysphoric Mood, Anhedonia/Negative Affect, Negative Self-Evaluation, and Somatic Complaints

    Change from 0 to 3 months

  • Multidimensional Anxiety Scale for Children (MASC)

    Self report measure of anxiety,with 39 items distributed across four major factors, three of which can be parsed into two subfactors each. Main and subfactors include (1) physical symptoms (tense/restless and somatic/autonomic), (2) social anxiety (humiliation/rejection and public performance fears), (3) harm avoidance (perfectionism and anxious coping), and (4) separation anxiety.

    Change from 0 to 3 months

Secondary Outcomes (6)

  • Children's Depression Rating Scale, Revised (CDRS-R)

    0, 3, and 6mos

  • Insomnia Severity Index (ISI)

    0, 3, and 6 mos

  • Affective Reactivity Index (ARI)

    0, 3, and 6 mos

  • The Avoidance and Fusion Questionnaire for Youth (AFQ-Y8)

    0, 3, and 6 mos

  • Child and Adolescent Mindfulness Measure (CAMM)

    0, 3, and 6 mos

  • +1 more secondary outcomes

Study Arms (1)

TARA Intervention group

EXPERIMENTAL

TARA is comprised of 12 weekly classes delivered in a group format by two trained facilitators with approximately 8-15 participants. The 90 minute sessions are designed to promote skills for autonomic regulation, attention modulation, emotion regulation and cognitive control.

Behavioral: TARA

Interventions

TARABEHAVIORAL

The intervention consists of four 3-week modules: 1. Autonomic regulation: Learning and practicing the ability to create a calm and safe inner state through breathing exercises and movement/physical activity. 2. Interoceptive awareness: Attention training, targeting external stimuli then sensory stimuli using short body scan exercises and guided meditations. 3.Emotion regulation: Recognizing, labeling, externalizing, and befriending emotions. 4. Metacognition, core-values, and committed action: Understanding social triggers to negative emotions and experiential avoidance strategies and their impact on obtaining desired life-goals. Home practice of TARA skills is encouraged, with breathing instructions and short, guided meditations provided via audio tracks.

TARA Intervention group

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years old, and not yet graduated from high school.
  • Post-pubertal (Tanner Stage , stage 3+).
  • CDRS-R score≥35 or MASC score≥56.
  • Currently under the care of a physician or mental health provider for depression and/or anxiety.

You may not qualify if:

  • Current comorbidity of psychosis, severe anorexia nervosa, PTSD, severe self-mutilation, severe suicidal ideation or attempt in past 3 mos.
  • Comorbidity (lifetime) of bipolar disorder, low-functioning autism spectrum disorder, intellectual disability (estimated intelligence quotient \< 80).
  • A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the group intervention.
  • Non English speaker.
  • Current mindfulness training (e.g. Mindfulness Based Stress Reduction or Mindfulness Based Cognitive Therapy or Dialectical Behavior Therapy) and/or practice with a typically sitting meditation or yoga of 20 or more minutes two or more times per week for the past two months.
  • Unable to attend study assessments and classes in San Francisco as scheduled.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Osher Center for Integrative Medicine

San Francisco, California, 94115, United States

Location

MeSH Terms

Conditions

DepressionAnxiety DisordersEmotional Regulation

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersSelf-ControlSocial Behavior

Study Officials

  • Rick M Hecht, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2015

First Posted

June 24, 2015

Study Start

January 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

March 22, 2022

Record last verified: 2022-03

Locations